Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
Vertex Pharma has said it will use a priority review voucher (PRV) to speed up the FDA review of its new once-daily triple therapy for cystic fibrosis, which has just hit all its objectives in a ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
The Institute for Clinical and Economic Review (ICER), which is the cost-effectiveness watchdog, said in its draft report that Vertex's painkiller is cost-effective only at a low price ...